The out-of-frame confirmed transcript represented FBXL20-ERBB2 fusion from the breast cancer sample BC105 which also had in-frame ATP2B1-ERBB2 fusion with the same RTK partner (Figure 2). Here, FBXL20 is linked to breast carcinoma.